NCT06729515Completed
Rhomboid Intercostal Block with Subserratus Plane Block in Bariatric Surgery
Rhomboid Intercostal Block with Subserratus Plane Block in Bariatric Surgery: a Three-arm Prospective Randomized Comparative Study
Source: ClinicalTrials.gov · Last updated 11 Dec 2024
Brief summary (registry, in English)
Standard analgesic techniques such as patient-controlled analgesia (PCA) and continuous epidural analgesia (CEA) are effective but associated with considerable side effects, including nausea, hypotension, and respiratory depression. This study aimed to evaluate the efficacy and safety of the rhomboid intercostal block combined with subserratus plane block (RISS) compared to PCA and CEA for postoperative analgesia in bariatric surgery.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 114 (actual)
- First submitted
- 4 Dec 2024
- Start date
- 1 Jan 2023
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Xiaguang Duan
- Diseases
- Obesity
- NCT number
- NCT06729515
What you commit to
- Study type: Interventional
- Participants enrolled: 114
- From 1 Jan 2023 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- severe cardiopulmonary or hepatic disease
- untreated major psychiatric disorders or active substance abuse potentially affecting postoperative lifestyle management; pregnancy or intention to conceive
Other
- inability to complete long-term follow-up or lifestyle adjustments; or inability to obtain complete trial data
- Patients who refused to provide written informed consent were excluded
Who the study is looking for
- aged 20-41 years
- ASA I-III
- body mass index (BMI) ≥27.5 kg/m² or BMI \<27.5 kg/m² with obesity-related comorbidities (type 2 diabetes mellitus, hypertension, obstructive sleep apnea, or non-alcoholic fatty liver disease)
- failure to achieve significant weight loss with conservative management (diet and/or pharmacotherapy)
- the capacity for postoperative care and lifestyle modification
Age in the registry: 20 years to 41 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Inner Mongolia Baogang Hospital Coordinator of this site? Confirm its status | Baotou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.